OrbiMed Asia GP IV, L.P.
Insider CIK 1966836 · KNTE Director, 10% owner · AVBP Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 84,599 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 450,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,338 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,339 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 4,738,453 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 821,827 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 821,827 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 1,291,442 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 1,291,442 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | P Buy | 2024-01-30 | 2024-01-31 | 222,222 | $18.00 | $4.00M | 1,513,664 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | P Buy | 2024-01-30 | 2024-01-31 | 222,222 | $18.00 | $4.00M | 1,513,664 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,512 | $2.82 | $1.38M | 1,368,339 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,511 | $2.82 | $1.38M | 1,368,338 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 312,991 | $2.75 | $860.7K | 4,738,453 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 220,610 | $2.67 | $589.0K | 4,425,462 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,544 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 467,068 | $2.62 | $1.22M | 4,204,852 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,545 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 228,754 | $2.55 | $583.3K | 3,737,784 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,997 | $2.55 | $155.5K | 610,997 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,998 | $2.55 | $155.5K | 610,998 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-23 | 550,000 | — | $0 | 550,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-23 | 550,000 | — | $0 | 550,000 | SEC↗ |